Today: January 16, 2018, 7:58 pm
  
Business

Oxford Immunotec to Present at the Jefferies 2017 London Healthcare Conference

PR-Inside.com: 2017-11-10 15:02:01

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that Peter Wrighton-Smith, Chief Executive Officer, will present at the Jefferies 2017 London Healthcare Conference at 8:00 a.m. GMT on Wednesday, November 15, 2017.

About Oxford Immunotec

Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions.  The Company's first product is the T-SPOT®.TB test, which is used to test for tuberculosis infection.  The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China.  The Company's second product line is a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics.  Also obtained through these acquisitions is the Company's third product line focused on screening for Babesia in donated blood, for which the Company is currently seeking FDA licensure.  The Company's fourth product line is focused on the transplantation market.  The Company is headquartered near Oxford, U.K. and in Marlborough, Mass.  Additional information can be found at www.oxfordimmunotec.com.

T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.  Immunetics is a trademark of Immunetics, Inc.

CONTACT:

For Media and Investor Inquiries:
Karen Koski
Head of Strategy and Investor Relations
Oxford Immunotec
Tel: +1 (508) 556-1377
kkoski@oxfordimmunotec.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Oxford Immunotec via Globenewswire




# 453 Words
Related Articles
More From The Author
Cintas Recognized as an Aon Best Employer [..]
Cintas Corporation : “Our employee-partners are a key component to our success and we are thrilled to be recognized with [..]
Algoma Central Corporation Announces Substantial Issuer Bid
Algoma Central Corporation (“Algoma”) (TSX:ALC) today announced that its Board of Directors has authorized a substantial issuer [..]
Golar LNG Partners LP: Q3 2017 results [..]
Golar LNG Partners LP 3rd Quarter 2017 results will be released before the NASDAQ opens on Thursday November 30, 2017. [..]
Golar LNG Limited - Q3 2017 results [..]
Golar LNG's 3rd Quarter 2017 results will be released before the NASDAQ opens on Thursday November 30, 2017. In connection [..]
Laurus Labs Records Healthy Performance, PAT Grows [..]
Laurus Labs Ltd. (Laurus BSE: 540222, NSE: Lauruslabs, ISIN. INE947Q01010), a leading research and development driven pharmaceutical company [..]
 
More From Business
Top 5 types of cryptocurrency used in [..]
The concept of commerce has changed significantly over the last decade. Before, manufacturers had to literally fight for the [..]
Belinvestbank JSC enables acceptance of JCB Cards [..]
Minsk and Tokyo, Jan 16, 2018 - (ACN Newswire) - Belinvestbank JSC ("Belinvestbank"), a leading bank in Belarus, and [..]
Convey Best Wishes by Sending Lucky Bamboo [..]
New Delhi, India: Life is moving at a much faster rate and people hardly find time to join for any [..]
Nam A Bank and JCB cooperate to [..]
Ho Chi Minh City, Jan 16, 2018 - (ACN Newswire) - Nam A Commercial Joint Stock Bank (Nam A Bank) [..]
Order online cakes, and Send your Love [..]
You can quickly order any cake on any occasion for any destination even at an odd hour all possible now [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.